UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regional Differences in Blood-Brain Barrier Permeability Changes and Inflammation in the Apathogenic Clearance of Virus from the Central Nervous System

Journal of Immunology, 2006-06, Vol.176 (12), p.7666-7675

2006

Volltextzugriff (PDF)

T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue

The Journal of immunology (1950), 2015-11, Vol.195 (9), p.4358-4368

2015

Volltextzugriff (PDF)

Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus

Proceedings of the National Academy of Sciences - PNAS, 2009-07, Vol.106 (27), p.11300-11305

2009

Volltextzugriff (PDF)

Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer

Matrix biology, 2018-09, Vol.70, p.20-35

2018

Volltextzugriff (PDF)

Brain tissue-resident immune memory cells are required for long-term protection against CNS infection with rabies virus

Future virology, 2020-11, Vol.15 (11), p.755-761

2020

Volltextzugriff (PDF)

Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinoma

Cancer biology & therapy, 2024-12, Vol.25 (1), p.2364433

2024

Volltextzugriff (PDF)

Systemic Immune Bias Delineates Malignant Astrocytoma Survival Cohorts

The Journal of immunology (1950), 2021-04, Vol.206 (7), p.1483-1492

2021

Volltextzugriff (PDF)

Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant

Journal of neurovirology, 2018-10, Vol.24 (5), p.606-615

2018

Volltextzugriff (PDF)

Intramuscular Inoculation of Mice with the Live-Attenuated Recombinant Rabies Virus TriGAS Results in a Transient Infection of the Draining Lymph Nodes and a Robust, Long-Lasting Protective Immune Response against Rabies

Journal of Virology, 2013-02, Vol.87 (3), p.1834-1841

2013

Volltextzugriff (PDF)

BP1003 Decreases STAT3 Expression and Its Pro-Tumorigenic Functions in Solid Tumors and the Tumor Microenvironment

Biomedicines, 2024-08, Vol.12 (8), p.1901

2024

Volltextzugriff (PDF)

Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models

Proceedings of the National Academy of Sciences - PNAS, 2007-03, Vol.104 (13), p.5656-5661

2007

Volltextzugriff (PDF)

Blood-Brain Barrier Changes and Cell Invasion Differ between Therapeutic Immune Clearance of Neurotrophic Virus and CNS Autoimmunity

Proceedings of the National Academy of Sciences - PNAS, 2008-10, Vol.105 (40), p.15511-15516

2008

Volltextzugriff (PDF)

Protection Against CNS-Targeted Rabies Virus Infection is Dependent upon Type-1 Immune Mechanisms Induced by Live-Attenuated Rabies Vaccines

Tropical medicine and infectious disease, 2017-07, Vol.2 (3), p.22

2017

Volltextzugriff (PDF)

A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient

Journal of Immunology, 2007-06, Vol.178 (11), p.7334-7343

2007

Volltextzugriff (PDF)

Therapeutic Intervention in Experimental Allergic Encephalomyelitis by Administration of Uric Acid Precursors

Proceedings of the National Academy of Sciences - PNAS, 2002-12, Vol.99 (25), p.16303-16308

2002

Volltextzugriff (PDF)

Rabies Virus Clearance from the Central Nervous System

Advances in Virus Research, 2011, Vol.79, p.55-71

2011

Volltextzugriff (PDF)

The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation

The Journal of pharmacology and experimental therapeutics, 2004-09, Vol.310 (3), p.1053-1061

2004

Volltextzugriff (PDF)

The Peroxynitrite Scavenger Uric Acid Prevents Inflammatory Cell Invasion into the Central Nervous System in Experimental Allergic Encephalomyelitis through Maintenance of Blood-Central Nervous System Barrier Integrity

The Journal of immunology (1950), 2000-12, Vol.165 (11), p.6511-6518

2000

Volltextzugriff (PDF)

Comparison of uric acid and ascorbic acid in protection against EAE

Free radical biology & medicine, 2002-11, Vol.33 (10), p.1363-1371

2002

Volltextzugriff (PDF)

Therapeutic immune clearance of rabies virus from the CNS

Future Virology, 2011-03, Vol.6 (3), p.387-397

2011

Volltextzugriff (PDF)

Prevention of Experimental Allergic Encephalomyelitis by Targeting Nitric Oxide and Peroxynitrite: Implications for the Treatment of Multiple Sclerosis

Proceedings of the National Academy of Sciences - PNAS, 1997-03, Vol.94 (6), p.2528-2533

1997

Volltextzugriff (PDF)

The Central Nervous System Inflammatory Response to Neurotropic Virus Infection Is Peroxynitrite Dependent

The Journal of immunology (1950), 2001-09, Vol.167 (6), p.3470-3477

2001

Volltextzugriff (PDF)

Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma

Clinical cancer research, 2021-04, Vol.27 (7), p.1912-1922

2021

Volltextzugriff (PDF)

Targeting VPAC1 receptors for imaging glioblastoma

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.1242

2018

Volltextzugriff (PDF)

ICAM-1 upregulation in the spinal cords of PLSJL mice with experimental allergic encephalomyelitis is dependent upon TNF-α production triggered by the loss of blood–brain barrier integrity

Journal of neuroimmunology, 2004-10, Vol.155 (1), p.32-42

2004

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(44)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Regional Differences in Blood-Brain Barrier Permeability Changes and Inflammation in the Apathogenic Clearance of Virus from the Central Nervous System

T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue

Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus

Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer

Brain tissue-resident immune memory cells are required for long-term protection against CNS infection with rabies virus

Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinoma

Systemic Immune Bias Delineates Malignant Astrocytoma Survival Cohorts

Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant

Intramuscular Inoculation of Mice with the Live-Attenuated Recombinant Rabies Virus TriGAS Results in a Transient Infection of the Draining Lymph Nodes and a Robust, Long-Lasting Protective Immune Response against Rabies

BP1003 Decreases STAT3 Expression and Its Pro-Tumorigenic Functions in Solid Tumors and the Tumor Microenvironment

Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models

Blood-Brain Barrier Changes and Cell Invasion Differ between Therapeutic Immune Clearance of Neurotrophic Virus and CNS Autoimmunity

Protection Against CNS-Targeted Rabies Virus Infection is Dependent upon Type-1 Immune Mechanisms Induced by Live-Attenuated Rabies Vaccines

A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient

Therapeutic Intervention in Experimental Allergic Encephalomyelitis by Administration of Uric Acid Precursors

Rabies Virus Clearance from the Central Nervous System

The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation

The Peroxynitrite Scavenger Uric Acid Prevents Inflammatory Cell Invasion into the Central Nervous System in Experimental Allergic Encephalomyelitis through Maintenance of Blood-Central Nervous System Barrier Integrity

Comparison of uric acid and ascorbic acid in protection against EAE

Therapeutic immune clearance of rabies virus from the CNS

Prevention of Experimental Allergic Encephalomyelitis by Targeting Nitric Oxide and Peroxynitrite: Implications for the Treatment of Multiple Sclerosis

The Central Nervous System Inflammatory Response to Neurotropic Virus Infection Is Peroxynitrite Dependent

Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma

Targeting VPAC1 receptors for imaging glioblastoma

ICAM-1 upregulation in the spinal cords of PLSJL mice with experimental allergic encephalomyelitis is dependent upon TNF-α production triggered by the loss of blood–brain barrier integrity

Suchergebnisse filtern